Mkts

Eton Pharmaceuticals, Inc.

NASDAQ: ETON
$68.40+0.86 (+1.27%)
As of Nov 11, 4:00 PM ET

Key statistics

Day range
64.7470.64
52-week range
14.2768.38
Today
Open66.94
Previous close68.40
Volume—
Valuation
Market cap1.97B
P/E ratio155.28×
EPS (TTM)0.39
Income & risk
Dividend / yield—
Beta0.81
Avg volume578.3K
Discussion

ETON News

Stories mentioning ETON from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue24,26621,28122,45918,92817,28211,64710,3249,074
Cost of Goods Sold9,5318,18114,6047,0047,4215,1714,0223,448
Gross Profit14,73513,1007,85511,9249,8616,4766,3025,626
Operating Expenses
Research & Development1,8751,7801,1123,7121,161(871.00)505.002,970
Sales General & Admin
Total Operating Expenses12,32110,6369,21813,39910,3315,8475,7938,561
Operating Income (Loss)2,4142,464(1,363)(1,475)(470.00)629.00509.00(2,935)
Interest Income
Interest Expense1,1361,2121,163211.00
Other Expense
Pretax Income1,5741,414(1,955)(2,519)(1,498)(511.00)501.00(2,987)
Tax Provision20.00(69.00)(28.00)66.0074.0087.00(126.00)54.00
Net Income (Loss)1,5541,483(1,927)(2,585)(1,572)(598.00)627.00(3,041)
Earnings Per Share (Basic)0.060.06(0.07)(0.10)(0.06)(0.02)0.02(0.12)
Earnings Per Share (Diluted)0.05(0.07)(0.06)0.02(0.12)
Weighted Average Shares Outstanding (Basic)27,28526,90826,89326,89326,88625,89525,90025,778
Weighted Average Shares Outstanding (Diluted)31,54726,89326,88626,55026.00

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About ETON

Eton Pharmaceuticals, Inc. (NASDAQ: ETON) is a stock listed on the Nasdaq Stock Market under the ticker symbol ETON. It last traded at $68.40 (Nov 11, 2026, 4:00 PM ET), up 1.3% on the day. That gives Eton Pharmaceuticals a market capitalisation of $2.0B and a price-to-earnings ratio of 155.3.

Over the past 52 weeks ETON has traded between $14.27 and $68.38.

Revenue for the quarter ended Mar 31, 2026 was $24.3M; net income $1.6M. Revenue was up 40.4% from $17.3M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$24.3M$1.6M6.4%
Dec 31, 2025$21.3M$1.5M7.0%
Sep 30, 2025$22.5M-$1.9M-8.6%
Jun 30, 2025$18.9M-$2.6M-13.7%

From Eton Pharmaceuticals’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…